NCT02538458View on ClinicalTrials.gov

Efficacy and Safety of 3% Hypertonic Saline Inhalation (24h vs 72h) to Treat Acute Bronchiolitis in Hospitalized Infants

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Bronchiolitis
Interventions
DRUG

3 % hypertonic saline up to 72H

Treatment by inhalation of 3 % hypertonic saline, up to 72H. Test group.

DRUG

3 % hypertonic saline up to 24H

"* Treatment by inhalation of 3 % hypertonic saline, up to 24H.~* followed by 48h of placebo : isotonic saline inhalation. Placebo control group."

Trial Locations (1)

38043

Hôpital Couple Enfant, Grenoble

All Listed Sponsors
collaborator

AGIR à Dom

OTHER

lead

University Hospital, Grenoble

OTHER

NCT02538458 - Efficacy and Safety of 3% Hypertonic Saline Inhalation (24h vs 72h) to Treat Acute Bronchiolitis in Hospitalized Infants | Biotech Hunter | Biotech Hunter